MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Macrogenics (MGNX) Misses Q1 EPS by 29c, Revenues Miss
April 29, 2021 4:59 PM EDTMacrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.90), $0.29 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $16.88 million versus the consensus estimate of $27.95 million.
With the recent launch and commercialization of MARGENZA, we are delivering on our vision to provide potentially... More
